Prevention of tau increase in cerebrospinal fluid of APP transgenic mice 
suggests downstream effect of BACE1 inhibition

Schelle, J.; Häsler, L.M.; Göpfert, J. C.; Joos, T.O.; Vanderstichele, H.; Stoops, E.; Mandelkow, Eva-Maria; Neumann, U.; Shimshek, D. R.; Staufenbiel, M.; Jucker, M.; Kaeser, S.A.

doi:doi: 10.1016/j.jalz.2016.09.005

Item

ITEM ACTIONSEXPORT

Add to Basket

Please note that a newer version of this item is available:
https://pure.mpg.de/pubman/item/item_2460816_3

DetailsSummary

Released

Journal Article

Prevention of tau increase in cerebrospinal fluid of APP transgenic mice suggests downstream effect of BACE1 inhibition

MPS-Authors

/persons/resource/persons128150

Mandelkow, Eva-Maria
Neuronal Cytoskeleton and Alzheimer's Disease, Cooperations, Center of Advanced European Studies and Research (caesar), Max Planck Society;

External Resource

http://www.sciencedirect.com/science/article/pii/S155252601632951X
(Publisher version)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Schelle, J., Häsler, L., Göpfert, J. C., Joos, T., Vanderstichele, H., Stoops, E., et al. (2017). Prevention of tau increase in cerebrospinal fluid of APP transgenic mice suggests downstream effect of BACE1 inhibition. Alzheimer's & Dementia, 13, 701-709. doi:doi: 10.1016/j.jalz.2016.09.005.

Cite as: https://hdl.handle.net/11858/00-001M-0000-002D-8BED-3

Abstract

There is no abstract available